Business Context and Reporting Period
Company: Gentherm Inc (THRM)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: Gentherm is a global leader in thermal management and pneumatic comfort technologies for the automotive and medical industries. The company operates two reportable segments: Automotive (97% of revenue) and Medical. Key products include Climate Control Seats, Climate Control Interiors, Lumbar and Massage Comfort Solutions, and patient temperature management systems.
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Product Revenues | $1,498.6 million | $1,456.1 million |
| Gross Margin | $362.2 million (24.2%) | $366.4 million (25.2%) |
| Operating Income | $82.7 million | $107.0 million |
| Net Income | $18.3 million | $64.9 million |
| Diluted EPS | $0.59 | $2.06 |
| Operating Cash Flow | $116.8 million | $109.6 million |
| Total Debt | $189.1 million | $220.2 million |
| Cash and Equivalents | $160.8 million | $134.1 million |
| Available Credit Facility | $307.9 million | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Product revenues increased 2.9% year-over-year, driven by favorable automotive volumes and foreign currency impacts (primarily the Euro), partially offset by unfavorable pricing and currency impacts from the Chinese Renminbi and Korean Won.
- Margin Compression: Gross margin decreased by 100 basis points to 24.2%. This was primarily due to higher quality costs, higher labor costs, and unfavorable foreign currency impacts, partially offset by material purchasing savings.
- Profitability Decline: Net income dropped significantly by 71.8% to $18.3 million. The decline was driven by a $38.0 million swing in foreign currency results (from a $9.6 million gain in 2024 to a $28.4 million loss in 2025), increased operating expenses, and a higher effective tax rate (49.0% in 2025 vs. 36.5% in 2024).
- Segment Performance: The Automotive segment generated $183.4 million in operating income, while the Medical segment reported a minimal operating income of $0.5 million, recovering from a loss in 2024.
- Restructuring: The company incurred $12.5 million in net restructuring expenses in 2025, related to optimizing the global manufacturing footprint.
Guidance, Outlook, and Risks
Modine Transaction
On January 29, 2026, Gentherm entered into definitive agreements to acquire Modine Manufacturing Company's Performance Technologies business via a Reverse Morris Trust transaction. The deal is expected to close in Q4 2026, subject to regulatory approvals and financing. Upon completion, existing Gentherm shareholders will own approximately 60% of the combined entity. The transaction involves a $790 million bridge loan facility.
Outlook and Trends
- New Business Awards: Secured an estimated $2.2 billion in automotive new business awards in 2025.
- Production Volumes: Global light vehicle production in key markets increased 3.7% in 2025, though 2026 is forecasted to decrease by 1.0%.
- Capital Allocation: The company repurchased $10.0 million of common stock in 2025. A $150 million repurchase program remains active with $110.1 million available.
Risks and Contingencies
- Geopolitical Risks: Ongoing conflicts in Ukraine and the Middle East impact supply chains and logistics. The Ukraine facility represents approximately 5% of total revenue.
- Trade Environment: Uncertainty regarding tariffs and trade restrictions, particularly involving the U.S. and China, poses risks to costs and demand.
- Goodwill Impairment: The Medical reporting unit's fair value exceeded its carrying value by only 25% as of December 31, 2025. Management notes this unit is at risk of failing future impairment tests if forecasted revenue growth (14% CAGR) is not achieved.
- Product Recalls: The company is involved in ongoing discussions regarding potential indemnification for Volkswagen and Porsche recalls related to seat heating mats and fuel tank systems. Costs cannot be reasonably estimated at this time.
Investor Verification Checklist
- Modine Transaction Status: Verify the progress of regulatory approvals and financing for the Modine acquisition, as failure to close could impact stock price and strategic growth.
- Foreign Currency Exposure: Monitor the impact of currency fluctuations (Euro, Renminbi, Won) on future margins, given the significant volatility seen in 2025.
- Medical Segment Viability: Assess the Medical segment's ability to meet aggressive growth assumptions to avoid potential goodwill impairment charges.
- Recall Liabilities: Track the resolution of the Volkswagen and Porsche recall matters to determine potential financial exposure.
- Tax Rate Volatility: Review future effective tax rates, as the 49.0% rate in 2025 was significantly higher than the statutory rate due to GILTI and withholding taxes.